IPO

Explore the landscape of IPO in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on IPO to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition
Policy / Regulatory

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

China's Ministry of Commerce (MOFCOM) and the Ministry of Science and Technology (MOST) jointly launched a public consultation on proposed revisions to the Catalogue of Technologies Prohibited or Restricted from…

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

AbbVie's RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

AbbVie’s RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Duality Biotherapeutics Makes Hong Kong IPO Debut with ADC Pipeline
CompanyDeals

Duality Biotherapeutics Makes Hong Kong IPO Debut with ADC Pipeline

Annoroad Gene Technology Files for IPO in Hong Kong
CompanyDeals

Chinese IVD Firm Annoroad Gene Targets Global Expansion with IPO

Duality Biotherapeutics Clears HKEX Hearing, Set for IPO with $2.7B Valuation
Company

Duality Biotherapeutics Clears HKEX Hearing, Set for IPO with $2.7B Valuation

Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services
CompanyDeals

Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services

PomDoctor Files for Nasdaq IPO to Expand Chronic Disease Management Services
CompanyDeals

PomDoctor Files for Nasdaq IPO to Expand Chronic Disease Management Services

Visen Pharmaceuticals IPO Launches on Hong Kong Stock Exchange Amid Growth in Endocrine Therapies
CompanyDeals

Visen Pharmaceuticals IPO Launches on Hong Kong Stock Exchange Amid Growth in Endocrine Therapies

Duality Biotherapeutics Updates IPO Filing with HKSE under Chapter 18A Rules
CompanyDeals

Duality Biotherapeutics Updates IPO Filing with HKSE under Chapter 18A Rules

Huge Dental Files for Hong Kong IPO with Diverse Dental Product Portfolio
CompanyDeals

Huge Dental Files for Hong Kong IPO with Diverse Dental Product Portfolio

Show More